Backed by Foresite Capital.
About the role
Jade is developing potentially transformational, disease-modifying therapies for people living with autoimmune diseases. With three biologics programs in the clinic and multiple ongoing studies from Phase I to Phase III, we are seeking an experienced Executive Director, Clinical Supply Management to join our CMC leadership team and make sure every patient in our trials receives the right investigational product, on time. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Manage IRT and inventory: Define supply requirements for IRT/IxRS systems, including resupply strategies and user acceptance testing, and monitor inventory at depots and sites to prevent stock-outs and minimize waste
- Own the budget and reporting: Manage the clinical supply budget, and report regularly and concisely to stakeholders and senior management on inventory, supply and demand, changes and risks across all programs
- Bachelor’s or Master’s degree (or equivalent) in Life Sciences, Chemical Engineering or a related field
- 15+ years of progressive experience in clinical supply chain management, ideally with biologics, including significant experience leading teams. Experience in commercial supply chain management is a plus
- Experience supporting multiple early- and late-stage programs, including multi-country Phase 3 studies and bridging studies for biologic combination products
- Comprehensive understanding of global regulatory and import/export requirements across Europe, North America, China, Japan and Rest of World (ROW), and strong working knowledge of cGMP, GDP and GCP
More about this role
About Jade Biosciences
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an anti-IFN-β monoclonal antibody. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn .
Role Overview
Jade is developing potentially transformational, disease-modifying therapies for people living with autoimmune diseases. With three biologics programs in the clinic and multiple ongoing studies from Phase I to Phase III, we are seeking an experienced Executive Director, Clinical Supply Management to join our CMC leadership team and make sure every patient in our trials receives the right investigational product, on time.
Reporting to the Chief Technology Officer (Head of CMC), you will own clinical...
Browse similar: Startup jobs · Remote jobs · San Francisco Bay Area